Effect of Folate on the Efficacy and Toxicity of Cancer Chemotherapy

Abstract

The purpose of this research project is to understand better the effect of dietary folate levels on the cellular pharmacology and toxicology of chemotherapeutic agents. The scope of the research involves in vitro studies with cell lines and in vivo assessments in rats of folate-chemotherapeutic drug interactions. Studies at a molecular level led to a new model to explain the synergy between nutritional folate deficiency and alkylating agents. Our studies at a cellular level suggest that folate metabolism can modulate glutathione levels. This observation may explain at least in part why dietary folate levels influence the efficacy and toxicity of alkylating agents. Studies in rats confirm that dietary folate levels affect the toxicity of cyclophosphamide but there may be an optimal amount of dietary folate to reduce that toxicity. These in vivo studies also indicate that other aspects of diet are important in determining sensitivity to chemotherapy. Rats maintained on a cereal-based diet were much more resistant to the toxic effects of cyclophosphamide than rats eating a Purified Diet. Taken together, our studies suggest that dietary changes can have a profound and largely unappreciated effect on the outcome of cancer chemotherapy.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 1999
Accession Number
ADA381230

Entities

People

  • John Mccormack
  • Richard F. Branda

Organizations

  • University of Vermont

Tags

DTIC Thesaurus Topics

  • Alkylating Agents
  • Blood
  • Blood Cells
  • Cancer
  • Cell Line
  • Cells
  • Chemistry
  • Chemotherapy
  • Genetics
  • Leukocytes
  • Lymphocytes
  • Metabolism
  • Neoplasms
  • Oncology
  • Rodents
  • Statistical Analysis
  • Vitamin C

Fields of Study

  • Biology
  • Medicine

Readers

  • Breast cancer cell signaling and growth regulation.
  • Neuroscience
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.